n accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), CDC announces the following meeting of 
the aforementioned committee:
    Times and Dates:
    9 a.m.-5 p.m., July 14, 2009.

[[Page 28711]]

    8:30 a.m.-1 p.m., July 15, 2009.
    Place: CDC, 1600 Clifton Road, NE., Building 19, Room 256/257, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 60 people.
    Purpose: The Secretary, Department of Health and Human Services 
(HHS), and, by delegation, the Director, Centers for Disease Control 
and Prevention (CDC), are authorized under Section 301 (42 U.S.C. 241) 
and Section 311 (42 U.S.C. 243) of the Public Health Service Act 
(PHSA), as amended to: develop and implement disease prevention and 
control, environmental health, and health promotion and health 
education activities designed to improve the health of the people of 
the United States. Under these and additional PHSA and other 
authorities, CDC acts by identifying and defining preventable health 
problems; maintaining active surveillance of diseases through 
epidemiologic and laboratory investigations and data collection, 
analysis, and distribution; conducting operational research aimed at 
developing and testing effective disease prevention, control, and 
health promotion programs; administering a national occupational safety 
and health program; controlling the introduction and spread of 
infectious diseases; and providing consultation and assistance to other 
nations and international agencies to assist in improving their disease 
prevention and control, environmental health, and health promotion 
activities. CDC carries out these functions through a number of 
Coordinating Centers/Offices and National Centers and Institutes with 
expertise and responsibilities in specific areas.
    Matters to be Discussed: The agenda will include discussions 
regarding two topics on which the BSC decided to focus its reviews: (1) 
Discovery activities (i.e., generation of knowledge, science and 
research); and (2) Diffusion activities (i.e., translation and transfer 
of knowledge to practice). Agenda items are tentative and subject to 
change.
    Contact Person for More Information: Dionne R. Mason, Committee 
Management Specialist, NCHM, 1600 Clifton Road, NE., Mail Stop E-21, 
Atlanta, Georgia 30333, Telephone: (404) 498-2314, Fax (404) 498-2221. 
The deadline for notification of attendance is June 30, 2009.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.